Autor: | Peter Brinsden, A. Gerrard, Fidelis Akagbosu, Amir Lass, N. Abusheikha |
---|---|
Rok vydání: | 2000 |
Předmět: |
Gynecology
endocrine system medicine.medical_specialty medicine.drug_class media_common.quotation_subject medicine.medical_treatment Obstetrics and Gynecology Physiology General Medicine Biology Embryo transfer Follicle-stimulating hormone Reproductive Medicine Follicular phase Genetics medicine Ovulation induction Gonadotropin Luteinizing hormone Ovarian reserve Ovulation hormones hormone substitutes and hormone antagonists Genetics (clinical) Developmental Biology media_common |
Zdroj: | Journal of Assisted Reproduction and Genetics. 17:566-573 |
ISSN: | 1058-0468 |
DOI: | 10.1023/a:1026485830540 |
Popis: | Objectives: The aim was to evaluate whether women who have early follicular follicle-stimulating hormone (FSH) levels >12 mIU/ml have reduced response to follicular stimulation for in vitro fertilization (IVF) in a following month, in spite of normal FSH levels. Materials and methods: In a 3-year period from January 1996 to December 1998, 303 women aged 38 years and above and/or who had previously responded poorly to superovulation for IVF gave blood samples for FSH, luteinizing hormone (LH), and estradiol (E2) on day 2 of menstruation before commencing treatment. Results: In 117 (38.6%) of these women, FSH levels were >12 mIU/ml (range 12–114 mIU/ml). Sixty-six of these women gave a further 130 blood samples for FSH measurement in the following months. Seventy-eight (60.0%) of the tests showed raised FSH value >12 mIU/ml. Thirty women whose repeat FSH levels were 12 mIU/ml had an increased risk (>50%) that in subsequent cycles levels would remain raised, and it was not possible to predict which individuals would have favorable FSH levels. If the cycle day 2 FSH level returns to a “normal” level of |
Databáze: | OpenAIRE |
Externí odkaz: |